Q: Please compare the two rail companies for projected revenue growth and your thoughts on growth and possible share price appreciation in the next one and three years timeframes.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Yesterday in your Webinar, you said "Sell the losers!"
I am down 44% in TSGI, 48% in VET and 35% in WEF. So are you! These stocks remain in your Portfolios.
Please help me understand what constitutes " A Loser" Thanks,
I am down 44% in TSGI, 48% in VET and 35% in WEF. So are you! These stocks remain in your Portfolios.
Please help me understand what constitutes " A Loser" Thanks,
Q: Good day gentlemen,
This company seems to hold 400M in cash. I believe that is roughly 2$ per share. Can you confirm? Also, the contract with Quebec is for 20k kilos in year 1, with increases every year for total c. 200k kilos over 5 years. I looked at the latest financials I could find on their site. It seams their selling price for past periods was 10$ per gram. I know that this is not possible with the Quebec contract. As a back of the envelope calculation, would it not be conservative to think they could NET 2$ or 3$ per gram on this contract.
Would that not make this stock extremely cheap? Also I notice most analysis is done on EV / Ebitda, can you explain the difference between this and P/E. why do they use this and not future P/E.
Thanks
This company seems to hold 400M in cash. I believe that is roughly 2$ per share. Can you confirm? Also, the contract with Quebec is for 20k kilos in year 1, with increases every year for total c. 200k kilos over 5 years. I looked at the latest financials I could find on their site. It seams their selling price for past periods was 10$ per gram. I know that this is not possible with the Quebec contract. As a back of the envelope calculation, would it not be conservative to think they could NET 2$ or 3$ per gram on this contract.
Would that not make this stock extremely cheap? Also I notice most analysis is done on EV / Ebitda, can you explain the difference between this and P/E. why do they use this and not future P/E.
Thanks
Q: Hi Guys,
What is your take on the EPS next month and also holding the company for 1-3 years.
Thanks
Anthony
What is your take on the EPS next month and also holding the company for 1-3 years.
Thanks
Anthony
Q: I get that the Marijuana stocks are coming back to earth, and that the whole industry is very much overvalued, but if I look at OGI and see that it is primed to earn 30 cents in 2020, on a fundamental basis it may be a tad expensive but we are not talking dot com or Bitcoin valuations are we? What am I missing?
Q: I own HEXO in the weed space. I see this stock and other majors have been falling since legalization. What do you think accounts for this? I'm speculating that a lot of people enjoyed the run up but set the legalization date as their exit point because a lot of companies' stock price will go downhill once they start reporting earnings. I'm thinking about selling to crystalize my 15% gain which was a 40% gain a few weeks ago. Thoughts? Comments?
Q: Your comments please on this small drug Co. Thanks
Q: While I realize that you've always been skeptical about the MJ sector as a whole, from an investment perspective, it might be time to take another look at CRZ in light of what has transpired in the past few months. It has recently acquired both 180 Smoke (Canada's premier vape store chain) and RVR Distribution (2017 revenue of US$25.3 million) which now gives it one of the dominant cannabis development platforms in California. This is significant because while there are currently 51 MJ stores in all of Canada, there are 450 in California. This likely explains why CRZ also had record Q2 revenue, accelerated the expiry date for its warrants (always a good sign) and boasts one of the best looking stock charts within the MJ sector.
-
Altria Group Inc. (MO $67.67)
-
Consumer Staples Select Sector SPDR (XLP $82.47)
-
Global X Marijuana Life Sciences Index ETF (HMMJ $8.71)
Q: Hello Team,
Is their an American tobaco ETF that covers these 3 stocks that are mentioned in your
5i Research report on the Marijuana Industry? ( Fantastic read).
Plus, all things considered between the 3, which individual stock is the most likely in your opinion to get involved in the Industry?
Thanks,
Stephen
Is their an American tobaco ETF that covers these 3 stocks that are mentioned in your
5i Research report on the Marijuana Industry? ( Fantastic read).
Plus, all things considered between the 3, which individual stock is the most likely in your opinion to get involved in the Industry?
Thanks,
Stephen
Q: You describe this as a cyclical stock. Can you explain the cycle that it follows? What would you look for to indicate a reversal?
Thank You
Thank You
Q: Thank you for the special report on marijuana. I bought in Canopy growth prior to the liberals getting elected on the advice of a friend who assumed they would win and legalized weed...then sold at $15 thinking it was way too overvalued.
I am wanting to invest in a company again, would Aphria not be the safest place to put some money? They actually earn a profit as you detailed, why is it not being valued as high? Is it because they are not really players in the recreational market (yet)? They have the lowest cost and make money, seems like the best play? What am I missing?
I am wanting to invest in a company again, would Aphria not be the safest place to put some money? They actually earn a profit as you detailed, why is it not being valued as high? Is it because they are not really players in the recreational market (yet)? They have the lowest cost and make money, seems like the best play? What am I missing?
Q: Your thoughts on the merger between IAN & MPX announced today. I think MPX shareholders receive 0.1673 shares of Ian for every MPX share?.
Thanks
Peter
Thanks
Peter
Q: Wondering if I could get an updated opinion on this company...last was August 2018...there has been some developments / news since then...I fully understand sector risk.....please and thank you
Q: Your opinion of ALEF please. Waterhouse has it
rated a strong buy.
Thank you JACK
rated a strong buy.
Thank you JACK
Q: I'm confused with your explanation on this arrangement. Please help me understand how many ACB shares I would get under the following two 20 Day VWAP scenarios:
If the VWAP is $10, how many would I get?
If the VWAP is $15, how many would I get?
Thanks as always for your amazing service!
If the VWAP is $10, how many would I get?
If the VWAP is $15, how many would I get?
Thanks as always for your amazing service!
Q: What do you think of this cannabis company in the US? Experienced board members. Same space as Alcann (cliq) in Canada. Issuing stock to buy pharma company. Touted as the apple of weed.
Value your opinion.
Value your opinion.
Q: I know you have reservations about the company's history and certain individuals, but momentum has been good recently. On Oct. 17 at midday, about 120,000 shares ($1 million) traded in a few minutes, which I assume was an institutional order. Total volume for the day was near 600,000 shares, which has only occurred a few other times earlier this year, when the share price was much lower. Are you aware of any increasing institutional interest in VMD?
-
Canopy Growth Corporation (WEED $1.77)
-
Aphria Inc. (APHA $16.55)
-
HEXO Corp. (HEXO $0.88)
-
Emerald Health Therapeutics Inc. (EMH)
Q: good morning all
What would be your recommendation for stocks in the medical marijuanna field
Thnks
CDJ
What would be your recommendation for stocks in the medical marijuanna field
Thnks
CDJ
Q: please advise of investing in cannibis. particularily Aurara.
L have invested in Horizon. Or others
L have invested in Horizon. Or others
Q: Is it time to sell and move on?